Delayed onset CMV disease in solid organ transplant recipients.
about
Role of human cytomegalovirus tegument proteins in virion assemblyCMV-Specific CD8 T Cell Differentiation and Localization: Implications for Adoptive TherapiesHLA-E-restricted cross-recognition of allogeneic endothelial cells by CMV-associated CD8 T cells: a potential risk factor following transplantation.Glucocorticosteroids trigger reactivation of human cytomegalovirus from latently infected myeloid cells and increase the risk for HCMV infection in D+R+ liver transplant patients.Infections in liver transplant recipients.Defining the risks for cytomegalovirus infection and disease after solid organ transplantation.Valganciclovir for the prevention and treatment of CMV in solid organ transplant recipients.Prevention of cytomegalovirus following solid organ transplantation: a literature review.Efficacy of valganciclovir and ganciclovir for cytomegalovirus disease in solid organ transplants: A meta-analysis.Cytomegalovirus Infection in Pediatric Solid Organ Transplant Recipients: a Focus on Prevention.Human cytomegalovirus antiviral drug resistance in hematopoietic stem cell transplantation: current state of the art.Potential role of CC chemokine receptor 6 in prediction of late-onset cytomegalovirus infection following solid organ transplant.Deep sequencing reveals highly complex dynamics of human cytomegalovirus genotypes in transplant patients over time.Association of the costimulatory molecule gene polymorphisms and active cytomegalovirus infection in hematopoietic stem cell transplant patients.Pharmacokinetics and exposure-response analysis of RG7667, a combination of two anti-cytomegalovirus monoclonal antibodies, in a Phase 2a randomized trial to prevent cytomegalovirus infection in high-risk kidney transplant recipients.Anemia as very late-onset cytomegalovirus disease after kidney transplantation.Factors associated with the development of cytomegalovirus infection following solid organ transplantation.
P2860
Q27015069-69E04057-B914-494E-8ED7-FF4B7D846011Q28073770-E30F5E5D-D253-47EE-BF2E-DE7257B7235CQ34506165-2B3A54D5-3975-4FF6-963E-08A2F06DE9BAQ34720787-9F01D127-6A0D-4FA6-9538-393985B55F8EQ34993661-C29EBF70-B2FC-4197-82C0-B7AF1EBF1E32Q37680941-25D913ED-F9A3-4139-BD49-C85AEE415D97Q37724248-5521B575-7613-483E-8EC6-9829E76B2B8DQ38124439-44CFB958-92A7-4A9A-9CB3-9A21D8B03BA3Q38364698-5CB2FC15-E102-4935-AC88-BB143389DCA3Q38689823-30D724E3-B3D9-46A8-8797-B36E313402FBQ38779846-2097155D-94D9-4B67-B44E-EBC4B7095959Q39037833-243A8DA7-DC06-4944-A0E7-2CDF4107AD86Q41897136-9AE5A592-F537-4239-A9D0-456773B3BD10Q42267746-88A698D4-2DF5-4A30-BFF9-BC6716AE7EFBQ45967035-5308F89F-F0F9-419F-8D8F-449A6DCEE05BQ48138605-33C3BAEA-F089-485C-BC38-19460888D030Q54388614-58B11401-5110-459B-B165-9E0C8D003E4C
P2860
Delayed onset CMV disease in solid organ transplant recipients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Delayed onset CMV disease in solid organ transplant recipients.
@en
Delayed onset CMV disease in solid organ transplant recipients.
@nl
type
label
Delayed onset CMV disease in solid organ transplant recipients.
@en
Delayed onset CMV disease in solid organ transplant recipients.
@nl
prefLabel
Delayed onset CMV disease in solid organ transplant recipients.
@en
Delayed onset CMV disease in solid organ transplant recipients.
@nl
P1476
Delayed onset CMV disease in solid organ transplant recipients.
@en
P2093
Carolynn E Pietrangeli
Shahid Husain
P356
10.1016/J.TRIM.2008.12.004
P577
2009-01-20T00:00:00Z